Literature DB >> 3689315

Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

C Freeman1, J J Hopwood.   

Abstract

Kinetic parameters (Km and kcat.) of the two major forms (A and B) and a minor form (C) of human liver N-acetylglucosamine-6-sulphate sulphatase [Freeman, Clements & Hopwood (1987) Biochem. J. 246, 347-354] were determined with a variety of substrates matching structural aspects of the physiological substrates in vivo, namely heparin, heparan sulphate and keratan sulphate. Enzyme activity is highly specific towards glucosamine 6-sulphate or glucose 6-sulphate residues. More structurally complex substrates, in which several aspects of the aglycone structure of the natural substrate were maintained, are hydrolysed with catalytic efficiencies up to 3900 times above that observed for the monosaccharide substrate N-acetylglucosamine 6-sulphate. Forms A and B both desulphate substrates derived from keratan sulphate and heparin. Aglycone structures that influence substrate binding and/or enzyme activity were penultimate-residue 6-carboxy and 2-sulphate ester groups for heparin-derived substrates and penultimate-residue 6-sulphate ester groups for keratan sulphate-derived substrates. The 4-hydroxy group of the N-acetylglucosamine 6-sulphate or the 2-sulphaminoglucosamine 6-sulphate under enzymic attack is involved in the catalytic mechanism. The presence of a 2-amino group in place of a 2-acetamido or a 2-sulphoamino group considerably decreases the catalytic efficiency of the sulphatase, particularly in the absence of a penultimate-aglycone-residue 6-carboxy group. Both forms A and B are exo-enzymes, since activity towards internal sulphate ester bonds was not observed. The effect of incubation pH on enzyme activity towards the variety of substrates evaluated was complex and dependent on substrate aglycone structure. The presence of aglycone 2-sulphate ester, 6-carboxy group and 6-sulphate ester groups on the glucosamine 6-sulphate residue under attack considerably affects the pH response. Sulphate and phosphate ions are potent inhibitors of enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689315      PMCID: PMC1148284          DOI: 10.1042/bj2460355

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Separation and properties of five glycosaminoglycan sulfatases from rat skin.

Authors:  H Habuchi; M Tsuji; Y Nakanishi; S Suzuki
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

2.  A glucosamine O,N-disulfate O-sulfohydrolase with a probable role in mammalian catabolism of heparan sulfate.

Authors:  B Weissmann; H Chao; P Chow
Journal:  Biochem Biophys Res Commun       Date:  1980-11-28       Impact factor: 3.575

3.  alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.

Authors:  J J Hopwood
Journal:  Carbohydr Res       Date:  1979-03       Impact factor: 2.104

4.  Sulphamidase activity in leucocytes, cultured skin fibroblasts and amniotic cells: diagnosis of the Sanfilippo A syndrome with the use of radiolabelled disaccharide substrate.

Authors:  J J Hopwood; H Elliott
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

5.  Biosynthesis of heparin. Concerted action of late polymer-modification reactions.

Authors:  I Jacobsson; U Lindahl
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

6.  Selective depolymerisation of heparin to produce radio-labelled substrates for sulfamidase, 2-acetamido-2-deoxy-alpha-D-glucosidase, acetyl-CoA:2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase, and 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase.

Authors:  J J Hopwood; H Elliott
Journal:  Carbohydr Res       Date:  1981-05-01       Impact factor: 2.104

7.  Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome.

Authors:  J J Hopwood; H Elliott
Journal:  Clin Chim Acta       Date:  1981-04-27       Impact factor: 3.786

8.  The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity.

Authors:  J J Hopwood; H Elliott
Journal:  Clin Chim Acta       Date:  1981-04-27       Impact factor: 3.786

9.  Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.

Authors:  H Kresse; E Paschke; K von Figura; W Gilberg; W Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Diagnostic enzymology of alpha-L-iduronidase with special reference to a sulphated disaccharide derived from heparin.

Authors:  J J Hopwood; V Muller
Journal:  Clin Sci (Lond)       Date:  1982-02       Impact factor: 6.124

View more
  17 in total

1.  A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases.

Authors:  M Y Galperin; A Bairoch; E V Koonin
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

2.  A rapid quantitative assay for the detection of mammalian heparanase activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Glucuronate-2-sulphatase activity in cultured human skin fibroblast homogenates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

4.  Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Authors:  J Bielicki; C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

5.  Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

6.  Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.

Authors:  P R Clements; D A Brooks; P A McCourt; J J Hopwood
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

7.  Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat.

Authors:  M Z Jones; L K Brumfield; B M King; J J Hopwood; S Byers
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

8.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

9.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization.

Authors:  C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

10.  A cDNA clone for human glucosamine-6-sulphatase reveals differences between arylsulphatases and non-arylsulphatases.

Authors:  D A Robertson; C Freeman; C P Morris; J J Hopwood
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.